Treatment with ATRA both in these stably transfected PML-RARα expressing U937 cells as well as in t(15;17)-carrying human AML cells (NB4) led to differentiation as verified by increased expression of myeloid markers such as CD11b and CD11c after 72 hours of treatment (S1 Fig). Here, PML is linked to acute myeloid leukemia.